本文選題：分枝桿菌 + 結(jié)核�。� 參考：《華東師范大學(xué)》2006年碩士論文

【摘要】：結(jié)核病(Tuberculosis，TB)是由結(jié)核分枝桿菌(Mycobacterium tuberculosis)引起的一種慢性傳染性疾病，是現(xiàn)在世界上最普遍和最嚴(yán)重的人類傳染病之一，也是全世界由單一致病菌致死最多的疾病之一。由于耐藥性結(jié)核桿菌的出現(xiàn)與傳播、艾滋病的流行以及人口的頻繁流動(dòng)等原因，結(jié)核病疫情呈現(xiàn)全球性的回升。吡嗪酰胺(Pyrazinamide，PZA)是治療結(jié)核病最有效的一線藥物之一，快速準(zhǔn)確的PZA耐藥性檢測(cè)技術(shù)對(duì)臨床治療及控制結(jié)核病具有重要的意義。吡嗪酰胺耐藥的精確的分子機(jī)理還未被闡明，對(duì)吡嗪酰胺耐藥相關(guān)基因pncA的突變進(jìn)行研究有很大的理論及應(yīng)用參考意義。 【目的】 本研究旨在建立起結(jié)核分枝桿菌吡嗪酰胺耐藥性的噬菌體生物擴(kuò)增(Phage Amplified Biologically Assay，PhaB)快速檢測(cè)方法，并探討和評(píng)價(jià)所建方法的實(shí)際應(yīng)用價(jià)值；同時(shí)對(duì)結(jié)核分枝桿菌PZA耐藥菌株的PZA耐藥相關(guān)基因pncA的突變進(jìn)行研究，對(duì)PZA耐藥機(jī)制進(jìn)行初步探索，為以后進(jìn)行PZA耐藥機(jī)制研究提供相關(guān)實(shí)驗(yàn)基礎(chǔ)。 【方法】 應(yīng)用PhaB法，對(duì)液體培養(yǎng)基的pH值、PZA藥物濃度、藥物作用時(shí)間進(jìn)行一系列實(shí)驗(yàn)，通過正交法篩選和優(yōu)化檢測(cè)條件，并對(duì)不同的噬菌體侵染環(huán)境的恢復(fù)方法進(jìn)行比較來(lái)確定最佳恢復(fù)方法；應(yīng)用所建方法對(duì)109株結(jié)核分枝桿菌臨床分離株進(jìn)行PZA耐藥性的測(cè)定，并將檢測(cè)結(jié)果與常規(guī)藥敏檢測(cè)方法結(jié)果進(jìn)行比較，對(duì)兩種方法檢測(cè)結(jié)果不相符的菌株進(jìn)行最低抑菌濃度(minimum inhibitory concentration，MIC)測(cè)定，以探討和評(píng)價(jià)所建方法的應(yīng)用價(jià)值；將結(jié)核分枝桿菌PZA耐藥株的耐藥相關(guān)基因pncA進(jìn)行PCR擴(kuò)增后對(duì)全基因進(jìn)行測(cè)序，對(duì)pncA基因突變進(jìn)行研究。 【結(jié)果】 PhaB法檢測(cè)PZA耐藥性的最佳條件為液體培養(yǎng)基pH值為5.5、PZA藥物濃度200ug／ml、37℃作用48小時(shí)，確定離心洗滌為噬菌體侵染環(huán)境的恢復(fù)方法。對(duì)109株結(jié)核分枝桿菌臨床分離株進(jìn)行PZA耐藥性測(cè)定，常規(guī)絕對(duì)濃度藥敏法檢測(cè)結(jié)果為敏感35株，耐藥74株；PhaB法檢測(cè)結(jié)果為敏感34株，耐藥75株，與絕對(duì)濃度法檢測(cè)結(jié)果的符合率為91.7％，對(duì)兩種檢測(cè)方法不相符的9株菌株進(jìn)行MIC測(cè)定，結(jié)果6株(3株敏感，3株耐藥)與PhaB法相符合，如以絕對(duì)濃度法測(cè)定PZA耐藥性結(jié)果為考核標(biāo)準(zhǔn)，，則PhaB法檢測(cè)PZA耐藥性的敏感性為94.6％(70／74)、特異性為85.7％(30／35)、陽(yáng)性預(yù)測(cè)值為93.3％(70／75)、陰性預(yù)測(cè)值為88.2％(30／34)、準(zhǔn)確性為91.7％(100／109)。與常規(guī)藥敏方法耗時(shí)長(zhǎng)達(dá)6-8周相比，PhaB法檢測(cè)PZA耐藥性僅需2-3天，但與常規(guī)藥敏方法符合率高且實(shí)驗(yàn)結(jié)果重復(fù)性好。對(duì)47株P(guān)ZA耐藥菌株進(jìn)行pncA基因測(cè)序，結(jié)果19株的pncA基因存在各種不同形式的突變，突變率達(dá)40.43％，在所有突變形式中，除已經(jīng)見報(bào)道的突變形式外，我們還發(fā)現(xiàn)了22個(gè)新的突變位點(diǎn)，這22種新的突變位點(diǎn)形成12種新的突變形式。 【結(jié)論】 PhaB法檢測(cè)結(jié)核分枝桿菌PZA耐藥性具有快速、操作簡(jiǎn)便、與常規(guī)藥敏方法符合率較高等特點(diǎn)，且不需要特殊儀器設(shè)備，所用試劑也是一般常
[Abstract]:Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (Mycobacterium tuberculosis). It is one of the most common and most serious human infectious diseases in the world. It is also one of the most fatal diseases in the world. The epidemic and the frequent flow of population show a global recovery. Pyrazinamide (PZA) is one of the most effective first-line drugs for the treatment of tuberculosis. Rapid and accurate detection of PZA resistance is of great importance to the clinical treatment and control of tuberculosis. The precise molecular mechanism of the drug resistance of the drug is the exact molecular mechanism of the drug resistance. It has not been elucidated yet. It is of great theoretical and practical significance to study the mutation of pncA.
[Objective] to establish a rapid detection method of Phage Amplified Biologically Assay (PhaB) for the drug resistance of Mycobacterium tuberculosis, and to explore and evaluate the practical application value of the method, and the mutation of PZA resistance related gene pncA of Mycobacterium tuberculosis resistant strain of Mycobacterium tuberculosis. The aim of this study is to explore the mechanism of PZA resistance and provide experimental basis for future research on the mechanism of PZA resistance.
[Methods] a series of experiments were carried out on the pH value of liquid medium, the concentration of PZA drug and the time of drug action by using PhaB method. The optimum recovery method was compared by orthogonal method and the methods of different phage infection environment were compared to determine the best recovery method. 109 strains of Mycobacterium tuberculosis were used in clinical practice. The isolates were tested for PZA resistance and compared with the results of conventional drug sensitivity test. The minimum inhibitory concentration (minimum inhibitory concentration, MIC) of the two strains which were not consistent with the test results were measured to explore and evaluate the application value of the established method, and the PZA resistant strains of Mycobacterium tuberculosis were used. The pncA gene was sequenced by PCR amplification, and the pncA gene mutation was studied.
[results] the best conditions for the detection of PZA resistance by PhaB were that the pH value of liquid medium was 5.5, the concentration of PZA was 200ug / ml, and the effect of 37 degrees centigrade was 48 hours. The method of centrifugal washing as the phage infection environment was determined. The drug resistance of 109 Mycobacterium tuberculosis clinical isolates was determined by PZA resistance, and the routine absolute concentration drug sensitivity test results were sensitive. There were 35 strains and 74 resistant strains. The results of PhaB detection were 34 sensitive, 75, 91.7%, and 9 strains which were not consistent with two detection methods. The results of 6 strains (3 sensitive, 3 resistant) were in conformity with the PhaB method, for example, the determination of the result of PZA resistance by absolute concentration method was P, then P The sensitivity of the haB method was 94.6% (70 / 74), the specificity was 85.7% (30 / 35), the positive predictive value was 93.3% (70 / 75), the negative predictive value was 88.2% (30 / 34), and the accuracy was 91.7%. Compared with the conventional drug sensitivity method, the PhaB method was only required to detect the PZA resistance, but it was with the conventional drug sensitivity method. The pncA gene was sequenced in 47 strains of PZA resistant strains, and the results of the 19 strains of pncA gene had various forms of mutation, the mutation rate was 40.43%. In all the mutation forms, we also found 22 new mutation sites except the reported mutation, and the 22 new mutation sites formed 1. 2 new forms of mutation.
[Conclusion] the detection of PZA resistance of Mycobacterium tuberculosis by PhaB is rapid, easy to operate, high in coincidence with conventional drug sensitivity methods, and does not require special instruments and equipment, and the reagents used are generally common.

【學(xué)位授予單位】：華東師范大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2006
【分類號(hào)】：R378.911

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 李洪敏,吳雪瓊,王巍,安慧茹,李燕鋒,劉瑞杰;結(jié)核菌耐藥pncA和embB基因突變與臨床治療的研究[J];中國(guó)醫(yī)師雜志;2004年06期

2 ;結(jié)核病診斷細(xì)菌學(xué)檢驗(yàn)規(guī)程[J];中國(guó)防癆雜志;1996年01期

3 ;結(jié)核病診斷細(xì)菌學(xué)檢驗(yàn)規(guī)程[J];中國(guó)防癆雜志;1996年03期

4 全國(guó)結(jié)核病流行病學(xué)抽樣調(diào)查技術(shù)指導(dǎo)組;第四次全國(guó)結(jié)核病流行病學(xué)抽樣調(diào)查報(bào)告[J];中華結(jié)核和呼吸雜志;2002年01期

5 胡忠義;結(jié)核分支桿菌耐藥性快速測(cè)定方法及其評(píng)價(jià)[J];中華結(jié)核和呼吸雜志;2003年02期

6 胡忠義,倪蓮娣,靳安佳,董惠賢,鐘敏,李建農(nóng),翁心華;噬菌體生物擴(kuò)增法快速檢測(cè)結(jié)核分枝桿菌方法學(xué)研究[J];中華結(jié)核和呼吸雜志;2004年12期

7 胡忠義,靳安佳,陳慧萍,崔振玲,景玲杰,王潔,翁心華;噬菌體生物擴(kuò)增法快速測(cè)定結(jié)核分枝桿菌利福平耐藥性[J];中華結(jié)核和呼吸雜志;2004年12期

8 胡忠義 ,李建農(nóng) ,靳安佳 ,張瑩蓉 ,王潔 ,崔振玲 ,翁心華;結(jié)核分枝桿菌鏈霉素耐藥性的噬菌體檢測(cè)技術(shù)研究[J];中華檢驗(yàn)醫(yī)學(xué)雜志;2005年08期

本文編號(hào)：1849150